Behind the Science: Behind Long-Term Acting Injectables for PrEP

Long-acting injectables are being studied for both HIV care and prevention and could help in changing the treatment paradigm from a daily oral regimen to a once monthly or even every 2 month injection for therapy. They have shown promise as a potential alternative to people dealing with pill fatigue, stigma, and quality of life issues associated with daily oral therapy. Clinicians offer insights into what medical community is doing right in this area where the challenges remain.